Protective efficacy of a SARS-CoV-2 DNA vaccine in wild-type and immunosuppressed Syrian hamsters.

Brocato, Rebecca L; Kwilas, Steven A; Kim, Robert K; Zeng, Xiankun; Principe, Lucia M; Smith, Jeffrey M; Hooper, Jay W

Brocato, Rebecca L; Kwilas, Steven A; Kim, Robert K; Zeng, Xiankun; Principe, Lucia M; Smith, Jeffrey M; Hooper, Jay W.

Afiliação

Brocato RL; Virology Division, United States Army Research Institute of Infectious Diseases, Frederick, MD, USA.
Kwilas SA; Virology Division, United States Army Research Institute of Infectious Diseases, Frederick, MD, USA.
Kim RK; Pathology Division, United States Army Research Institute of Infectious Diseases, Frederick, MD, USA.
Zeng X; Pathology Division, United States Army Research Institute of Infectious Diseases, Frederick, MD, USA.
Principe LM; Virology Division, United States Army Research Institute of Infectious Diseases, Frederick, MD, USA.
Smith JM; Virology Division, United States Army Research Institute of Infectious Diseases, Frederick, MD, USA.
Hooper JW; Virology Division, United States Army Research Institute of Infectious Diseases, Frederick, MD, USA. jay.w.hooper.civ@mail.mil.

NPJ Vaccines ; 6(1): 16, 2021 Jan 25.

Article em En | MEDLINE | ID: mdl-33495468

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: NPJ Vaccines Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google